Investing.com - Carl Zeiss Meditec ADR reported on Friday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Carl Zeiss Meditec ADR announced earnings per share of $0.7134 on revenue of $486.54M. Analysts polled by Investing.com anticipated EPS of $0.7116 on revenue of $486.31M.
Carl Zeiss Meditec ADR shares are down 13.05% from the beginning of the year and are trading at $126.68 , down-from-52-week-high.They are under-performing the EUR/USD which is down 0% from the start of the year.
Carl Zeiss Meditec ADR follows other major Healthcare sector earnings this month
Carl Zeiss Meditec ADR's report follows an earnings beat by Medtronic on Tuesday, August 23, 2022, who reported EPS of $1.13 on revenue of $7.37B, compared to forecasts EPS of $1.12 on revenue of $7.22B.
Merck ADR had beat expectations on Friday with third quarter EPS of $0.5392 on revenue of $5.69B, compared to forecast for EPS of $0.5165 on revenue of $5.57B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar